Progressive grey matter atrophy over the first 2-3 years of illness in first-episode schizophrenia: a tensor-based morphometry study

scientific article published on 3 May 2006

Progressive grey matter atrophy over the first 2-3 years of illness in first-episode schizophrenia: a tensor-based morphometry study is …
instance of (P31):
scholarly articleQ13442814

External links are
P8978DBLP publication IDjournals/neuroimage/WhitfordGFGBHGW06
P356DOI10.1016/J.NEUROIMAGE.2006.03.041
P698PubMed publication ID16677830
P5875ResearchGate publication ID7102885

P50authorStuart M. GrieveQ42434227
Tom FarrowQ42757920
P2093author name stringJohn Brennan
Leanne M Williams
Thomas J Whitford
Lavier Gomes
Evian Gordon
Anthony W F Harris
P433issue2
P407language of work or nameEnglishQ1860
P921main subjectschizophreniaQ41112
P304page(s)511-519
P577publication date2006-05-03
P1433published inNeuroImageQ1981225
P1476titleProgressive grey matter atrophy over the first 2-3 years of illness in first-episode schizophrenia: a tensor-based morphometry study
P478volume32

Reverse relations

cites work (P2860)
Q94348002Q94348002
Q33525203A systematic review of the effects of antipsychotic drugs on brain volume
Q33296098Abnormal oscillatory brain dynamics in schizophrenia: a sign of deviant communication in neural network?
Q36654213Abnormalities of middle longitudinal fascicle and disorganization in patients with schizophrenia
Q31153621Anatomical abnormalities of the anterior cingulate cortex in schizophrenia: bridging the gap between neuroimaging and neuropathology
Q34151554Are Bipolar Disorder and Schizophrenia Neuroanatomically Distinct? An Anatomical Likelihood Meta-analysis.
Q48626810Brain differences in first-episode schizophrenia treated with quetiapine: a deformation-based morphometric study
Q45163957Cerebellar grey-matter deficits, cannabis use and first-episode schizophrenia in adolescents and young adults
Q36958178Cerebral disconnectivity: an early event in schizophrenia
Q47221991Clinical and neurocognitive course in early-onset psychosis: a longitudinal study of adolescents with schizophrenia-spectrum disorders.
Q48460836Common pattern of gray-matter abnormalities in drug-naive and medicated first-episode schizophrenia: a multimodal meta-analysis.
Q57464939Diverse definitions of the early course of schizophrenia-a targeted literature review
Q51900054Effects of aripiprazole and haloperidol on progression to schizophrenia-like behavioural abnormalities and apoptosis in rodents
Q34496393Excessive extracellular volume reveals a neurodegenerative pattern in schizophrenia onset
Q34673324Fiber pathway pathology, synapse loss and decline of cortical function in schizophrenia
Q37127470Fiber tractography reveals disruption of temporal lobe white matter tracts in schizophrenia
Q34013842G72 influences longitudinal change in frontal lobe volume in schizophrenia
Q48155090Gray matter alterations in first-admission adolescents with schizophrenia
Q34415975Gray matter in first-episode schizophrenia before and after antipsychotic drug treatment. Anatomical likelihood estimation meta-analyses with sample size weighting.
Q34355445Gray matter loss in young relatives at risk for schizophrenia: relation with prodromal psychopathology
Q57536745Gray matter volume deficits and correlation with insight and negative symptoms in first-psychotic-episode subjects
Q34500685Inherent Structure-Based Multiview Learning With Multitemplate Feature Representation for Alzheimer's Disease Diagnosis
Q36807765Integrating objective gene-brain-behavior markers of psychiatric disorders
Q33411428Is schizophrenia a neurodegenerative disorder?
Q37044422Is schizophrenia a syndrome of accelerated aging?
Q41857458Is there a degenerative process going on in the brain of people with Schizophrenia?
Q92319642Long-Term Grey Matter Changes in First Episode Psychosis: A Systematic Review
Q24643949Longitudinal brain changes in early-onset psychosis
Q35592555Longitudinal loss of gray matter volume in patients with first-episode schizophrenia: DARTEL automated analysis and ROI validation
Q36247687Magnetic resonance imaging correlates of first-episode psychosis in young adult male patients: combined analysis of grey and white matter
Q33950987Morphometric brain abnormalities in schizophrenia in a population-based sample: relationship to duration of illness
Q30405077Oligodendroglial alterations and the role of microglia in white matter injury: relevance to schizophrenia
Q42279142Parietal lobes in schizophrenia: do they matter?
Q37100414Progression of brain volume changes in adolescent-onset psychosis
Q36395044Progressive brain change in schizophrenia: a prospective longitudinal study of first-episode schizophrenia
Q42182641Progressive brain changes in schizophrenia
Q35898965Regional Abnormality of Grey Matter in Schizophrenia: Effect from the Illness or Treatment?
Q34337272Relapse duration, treatment intensity, and brain tissue loss in schizophrenia: a prospective longitudinal MRI study.
Q61447355Reproducible grey matter patterns index a multivariate, global alteration of brain structure in schizophrenia and bipolar disorder
Q30475598Research in people with psychosis risk syndrome: a review of the current evidence and future directions
Q34701033Similar age-related decline in cortical activity over frontotemporal regions in schizophrenia: a multichannel near-infrared spectroscopy study.
Q39727461Statistical epistasis and progressive brain change in schizophrenia: an approach for examining the relationships between multiple genes.
Q36117393Structural abnormalities in the cuneus associated with Herpes Simplex Virus (type 1) infection in people at ultra high risk of developing psychosis
Q40547311Structural brain changes are associated with response of negative symptoms to prefrontal repetitive transcranial magnetic stimulation in patients with schizophrenia
Q34393431Structural brain changes associated with antipsychotic treatment in schizophrenia as revealed by voxel-based morphometric MRI: an activation likelihood estimation meta-analysis
Q33721022Structural neuroimaging in schizophrenia from methods to insights to treatments
Q43604840Tensor-based morphometry of cannabis use on brain structure in individuals at elevated genetic risk of schizophrenia.
Q28077138The Longitudinal Course of Schizophrenia Across the Lifespan: Clinical, Cognitive, and Neurobiological Aspects
Q33865677The anatomy of first-episode and chronic schizophrenia: an anatomical likelihood estimation meta-analysis
Q35154166The benefit of minocycline on negative symptoms in early-phase psychosis in addition to standard care - extent and mechanism (BeneMin): study protocol for a randomised controlled trial
Q24643935The concept of progressive brain change in schizophrenia: implications for understanding schizophrenia
Q48952912The effects of gender on grey matter abnormalities in major psychoses: a comparative voxelwise meta-analysis of schizophrenia and bipolar disorder.
Q38582714The lifetime trajectory of schizophrenia and the concept of neurodevelopment
Q41535826The neurobiology of transition to psychosis: clearing the cache.
Q48696487The optic radiation and the cerebellar peduncles in adolescents with first-admission schizophrenia--a diffusion tensor imaging study
Q55312155The relationship between clinical insight and cognitive and affective empathy in schizophrenia.
Q48358708View-centralized multi-atlas classification for Alzheimer's disease diagnosis
Q38384706fMRI changes over time and reproducibility in unmedicated subjects at high genetic risk of schizophrenia

Search more.